Introduced Version






HOUSE BILL No. 1350

_____


DIGEST OF INTRODUCED BILL



Citations Affected: None (noncode).

Synopsis: Appropriation for clinical trials. Appropriates $20,000,000 from the tobacco master settlement agreement fund to the biomedical technology and basic research trust fund to provide funding for clinical trials to study the use of experimental drugs for the treatment or prevention of human diseases.

Effective: July 1, 2002.





Dumezich




    January 15, 2002, read first time and referred to Committee on Ways and Means.







Introduced

Second Regular Session 112th General Assembly (2002)


PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional provision adopted), the text of the new provision will appear in this style type. Also, the word NEW will appear in that style type in the introductory clause of each SECTION that adds a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts between statutes enacted by the 2001 General Assembly.

HOUSE BILL No. 1350



    A BILL FOR AN ACT concerning medical research funding and to make an appropriation.

Be it enacted by the General Assembly of the State of Indiana:

SOURCE: ; (02)IN1350.1.1. -->     SECTION 1. [EFFECTIVE JULY 1, 2002] Notwithstanding IC 4-12-1-14.3 , there is appropriated to the biomedical technology and basic research trust fund twenty million dollars ($20,000,000) from the Indiana tobacco master settlement agreement fund for use in providing funding to public and private entities located in Indiana for clinical trials to study the use of experimental drugs for the treatment or prevention of human diseases.